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Abstract  
AIM: Verification bias is one of the major problems encountered in diagnostic accuracy studies. It occurs when a 
standard test performed on a non-representative subsample of subjects which have undergone the diagnostic 
test. In this study we extend a Bayesian model to correct this bias.  
METHODS: The study population is patients that have undergone at least two repeated failed IVF/ICSI (in vitro 
fertilization/intra cytoplasmic sperm injection) cycles. Patients were screened using ultrasonography and those 
with polyps were recommended for hysteroscopy. A Bayesian modeling was applied on mechanism of missing 
data using an informative prior on disease prevalence. The parameters of the model were estimated through 
Markov Chain Monte Carlo methods. 
RESULTS: A total of 238 patients were screened, 47 of which had polyps. Those with polyps were strongly 
recommended to undergo hysteroscopy, 47/47 decide to have a hysteroscopy and in 37/47 polyps confirmed. 
None of the 191 patients with no polyps detected in ultrasonography underwent a hysteroscopy. A model using 
Bayesian approach was applied with informative prior on polyp prevalence. False and true negatives were 
estimated in the Bayesian framework. The false negative was obtained 14 and 177 true negatives were obtained, 
so sensitivity and specificity was estimated easily after estimating the missing data. Sensitivity and specificity 
were equal to 74% and 94% respectively. 
CONCLUSION: Bayesian analyses with informative prior seem to be powerful tools in the simulation of 
experimental space. 
 
 
 
 
 
Introduction 
 
Advances in medical technology have 
provided doctors with the various ways of diagnostic 
methods to identify patients. Diagnostic accuracy 
studies help physicians in selecting the most 
appropriate test to evaluate the patient’s clinical 
situation and decision making about treatment by 
examining the characteristics of these tests. The 
sensitivity and specificity of diagnostic tests are 
assessed by comparing the results of evaluated tests 
with result of the standard test that is performed on 
the same patients. Generally the most accurate test 
for diagnosis is considered as the gold standard. For 
evaluation of the diagnostic test in best situation both 
tests are performed for all study subjects. One of the 
problems often encountered in these studies is that 
due to it being costly or invasive. The standard test is 
not performed on all the study subjects. This seems 
reasonable in the clinic setting but in a diagnostic test 
study it creates verification bias [1]. Verification bias is 
a selection bias and occurs when the standard test 
performed on a non-representative subsample of 
study subjects which have already undergone the 
diagnostic test. This occurs, for example, when 
inclusion probabilities for the subsample are 
dependent on the initial stage results and/or on a 
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covariate related to the disease status. This bias is 
usually divided into two types: differential bias and 
partial bias. Partial verification bias occurs when 
standard test is only performed on patients who have 
a positive diagnostic test result. Differential verification 
bias occurs when standard test which perform on 
patients with positive test result, is different to the 
standard test that is performed on patients who have 
a negative result [1] [2]. In most studies, there is no 
result for gold standard test for some people and any 
kind of verification bias are considered from the 
viewpoint of missing data. So there is no result for 
gold standard test for some people. Models that are 
built based on this view are dependent on the process 
of missing data. Begg and Greenes were the first 
researchers who tried to correct the partial verification 
bias [3]. They used the diseased proportion of the 
sample which had been used to perform the gold 
standard test on. Their models were based on the 
conditional independency assumption; this 
assumption means that missing process or sample 
selection to done gold standard only dependent on the 
test result and not on the true disease status. On the 
other hand, missing event of a sample given the test 
result is independent of true disease status. Some 
researchers think this assumption is unrealistic and in 
some cases this can be misleading [4] [5]. But 
Kosinski [6] tried to overcome this problem by 
considering that in addition to the test result, the 
missing process was dependent on the true disease 
status and unobserved information about the disease 
[5] [7]. Obviously, having the full data we could 
compare the different models in predicting the results 
of the gold standard test. Estimation of the models 
was based on Frequentist and maximum likelihood 
approach. Problems in these methods are described 
in Martinez and Buzoianu [5] [7]. It seems that 
problems of these methods are due to a new variable 
called v which is defined as the missing process. In 
this article we have covered the missing process and 
problems associated with it which have not been 
studied before. We eliminated the variable  using a 
new definition and fitted a new Bayesian model that is 
not dependent on . In section 2, we proposed the 
detailed model in the Bayesian framework to estimate 
sensitivity and specificity. In section 3, a real data 
example is described and the Bayesian model is 
applied and the results are presented. Finally, In 
Section 4 we discuss the model and its results.  
Let that missing process occurs 
simultaneously with the result of the diagnostic test 
[7]. On the other hand, if the test result was positive, 
the gold standard test should be performed but if the 
result was negative the gold standard test is not 
performed. The test process is depicted below:  
 
Therefore, the probability of missing is zero 
for a positive test result and 1 for a person with a 
negative result. If T represents the diagnostic test 
result and V represents the missing process, the 
following probability exists. 
 
 
 
If G represents the gold standard result then 
the aim is to find a function to predict the gold 
standard status for individuals with a negative 
diagnostic test result. Thus, sensitivity and specificity 
could be estimated. The model is started with 
following probability: 
 
 
 Where according to the definition 1, 
probability [2] exists in the following form: 
 
 
 
As we considered (1) T and V to occur 
simultaneously, information about the events T and G 
gives full information about V. therefore the 
relationship [3] can be rewritten as bellow: 
 
So, it can be concluded that the missing 
process is independent of the disease status given the 
diagnostic test status (it can be assumed that the 
disease status will be clarified by the gold standard 
test), but the disease status has direct impact on the 
missing process. For example, in someone who is 
suffering from a disease, the probability of a positive 
diagnostic and the missing probability are low. Table 1 
is a cross table which illustrates the diagnostic test 
and gold standard frequencies. 
Table 1: Diagnostic test and gold standard result 
 Positive Gold standard Negative Gold standard 
Positive test 
  
Negative test 
  
 
Probability could be obtained by the 
following: 
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Where,  and  are the 
sensitivity (SN) and specificity (SP) of the diagnostic 
test respectively. A reasonable initial model is to 
assume that the number of each cell }i,j=1,2 has the 
following distribution 
 
 
 
 
 
 
Therefore, the posterior probability function 
for disease prevalence is: 
 
Proof of the formulas is given in Appendix A. 
Repeated IVF failures are one of the 
problems of infertility centers. Structural abnormalities 
in uterine cavity such as fibroids and mullerian 
anomalies can play an important role in the failure of 
embryo implantation during IVF cycles [8]. Repair of 
uterine cavity pathologies has been suggested as a 
therapeutic action to improve the results of ART 
cycles in these individuals. Hysteroscopy is 
considered as a gold standard test for evaluating the 
uterine cavity in infertile patients. This method allows 
direct observation of the uterus and cervix, Thus 
Increasing the accuracy of diagnosis. This can also 
highlight uncertain results of other diagnostic methods 
[9]. Uterine anomalies are usually well diagnosed with 
hysteroscopy [10]. A number of studies reported that 
sensitivity, specificity, positive predictive value and 
negative predictive value of transvaginal sonography 
is similar to the results of hysteroscopy [8]. Some 
studies also found no strong correlation between the 
result of transvaginal sonography and hysteroscopy 
[11]. It is recommended that all women undergoing 
IVF candidates, before doing IVF placed under 
hysteroscopy [12]. But given that hysteroscopy is an 
invasive procedure, maybe it is not performed on all 
patients who assessed using transvaginal 
sonography, and done only for patients who have had 
positive results of transvaginal sonography. 
Consequently verification bias occurs.  
 At First we have analyzed the data obtained 
from 140 patients admitted to the Royan Institute, and 
transvaginal sonography and hysteroscopy was 
performed for every one of them, these patients have 
at least two Repeated IVF/ICSI cycles which have 
failed. With regard to Hysteroscopy as the gold 
standard, we calculated the sensitivity and specificity 
of vaginal sonography in detecting polyps with the 
frequentist method, then with assuming that 
Hysteroscopy has been performed only on patients 
who have positive results of vaginal sonography. We 
estimated the sensitivity and specificity of vaginal 
sonoghraphy with Bayesian approach and compared 
these estimations with sensitivity and spasticity of the 
actual data.  
Since there was expert belief about disease 
prevalence but not about sensitivity and specificity, we 
therefore formulated those in terms of disease 
prevalence. Furthermore, to account for the 
uncertainty of prevalence, we used the Beta 
distributions as informative. Hyper-parameters 
 were determined by subjective percentiles 
technique [13]. The prior information was provided by 
a gynecologists and a midwife independently. Each 
expert provided the best guess and a 90% prior 
credible interval for the prevalence. In particular we 
wanted upper boundaries and lower bound, without 
consulting the Literature, of the true value of the polyp 
prevalence in the population. The across-expert 
average of these quantities is listed below: 
 
 
The averaged credible interval for prevalence 
is used to determine the hyperparameters  and . 
 
In the present setting, for instance, a Monte 
Carlo sample of 100000 draws from the prior which 
gives , so the prior 
information is being represented as desired. 
Prior distribution of prevalence must be 
truncated from 0.15 because generated numbers 
below this cut point cause sensitivity and specificity to 
become negative. Therefore, the truncated beta 
distribution has been truncated between 0.15 and 1. 
There is no truncated distribution in OpenBugs; the I 
(.,.) operator is used only to denote censored 
observation [14]. However, when all parameters in a 
prior distribution are observed, the I (.,.) operator can 
be used for modeling truncated prior distributions. If 
there are unknown parameters the inferences will be 
wrong [15]. OpenBugs remove this ambiguity between 
truncation and censoring by introducing the truncation 
operator T (.,.) [16]. 
Therefore, the prior density for  is 
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We apply the model to real data that was 
introduced previously. In total 238 patients were 
undergoing ultrasound tests for the diagnosis of 
polyps. 191 people had negative test results and 47 
had positive results. The gold standard test was then 
done for two groups. The results are showed in Table 
2. 
Table 2: Results of diagnostic and gold standard tests 
 
 
 
 
 
   
   
 
Thus, the sensitivity, specificity, positive and 
negative predictive value is easily calculated as 
follows: 
 
 
 
 
But the problem will be started when the gold 
standard test is not performed on people with negative 
diagnostic test results. So Table 2 comes in the form 
below: 
Table 2: A contingency table that depict missing mechanism 
   
   
   
NA: Not Available. 
 
In Bayesian approach, model [6] is posterior 
density function of disease prevalence. The parameter 
of the model [1] was estimated using simulation from 
the posterior distribution. The Markov Chain Monte 
Carlo (MCMC) method using Adaptive Metropolis 
Block was applied [13]. Algorithm was run in 
OpenBugs 3.1.2 environment [14] [15]. After 10000 
times iteration the chain was converged to posterior 
distribution and 5000 initial samples were discarded 
as Burn-in period. Graphical methods such as 
autocorrelation function, posterior density and trace 
plot were used for checking convergence of chains 
[16] (not shown). The program was run in OpenBugs 
given in Appendix 2. Bayesian Results after sampling 
(simulation) were shown in Table 3. 
Table 3: Estimation of parameters simulated by MCMC 
algorithm in Bayesian framework 
Sample Start 97.5 
credible 
interval 
2.5 credible 
interval 
Standard 
deviation 
Posterior 
mean 
Parameters 
01111 1110 0.925 0.5139 1901.0 0.7417 Sensitivity 
01111 1110 0.9842 0.8289 0.0411 0.9272 Specificity 
01111 1110 0.8868 0.6578 0.0586 198010 
 
PPV 
01111 1110 0.9783 0.83 0.03828 0.9269 NPV 
 
 
 
Discussion 
 
Verification bias is a type of selection bias that 
occurs when the standard test performed on a non-
representative subsample of study subjects which 
have already undergone the diagnostic test. In most 
studies there is no result for gold standard test for 
some people. There are several ways to solve this 
problem. For example we assume that results of the 
gold standard test are negative for all these people. 
This approach is clinically inappropriate. Since there is 
a possibility of error in diagnostic test and 
consequently negative predictive value may not be 1. 
This method greatly increased the sensitivity and 
specificity values and therefore overestimation can 
occur. Another way is results of previous tests for 
people who have had the gold standard test to be 
replaced. The estimates from this strategy could be 
subject to bias, because the conditions governing the 
present situation may be different from any of the 
previous experiments. In this paper a new statistical 
model was presented based on conditional 
probabilities where the model parameters, sensitivity 
and specificity, was estimated from the Bayesian 
approach [17]. The conditional probabilities are the 
same positive and negative predictive values which 
provide information about the model. The data 
missing process is different from other corresponding 
studies, meaning the gold standard results do not 
exist for individuals with a negative test. The 
assumption of conditional independence that was 
used by Begg and Greenes is quite applicable in case 
of missing process of current data. When a patient’s 
diagnostic test is specified then the missing state is 
determined automatically. Thus the disease status is 
independent of the missing process given knowing the 
diagnostic test result. On the other hand, the actual 
status of the disease increases or decreases the 
chances of missing. So the model can be defined 
based on conditional probabilities . To 
construct better models and predict the missing 
values more accurately, information must enter the 
study according to an expert’s opinion because the 
probability distribution does not give enough 
information about the missing values. This could be 
done with considering the disease prevalence in the 
population as uncertain and attributing the probability 
distribution to it. This can give useful information to 
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the model about the overall distribution of the gold 
standard. The proposed model is for diagnostic test 
ultrasound against the gold standard hysteroscopy in 
detection of polyps. But whether or not it can be 
applied to other tests, should be studied to allow the 
estimation of the parameters, after the probability of 
disease combined with the distribution of diagnostic 
tests. Finally, we hope stronger and more powerful 
Models in the development of diagnostic tests can be 
developed in the future. 
 
Appendix A: 
Proofs of formula (4) and (5): 
 
 
 
 
 
 
Appendix B: Openbugs codes 
In order to run the model with informative beta 
distribution for prevalence of disease the following 
code was used: 
model{ 
PG1~dbeta(2,12) T(0.1541400874,1) 
SN<-(0.7858*10)/(0.2142*238*PG1) 
SP<-((238*(1-PG1))-10)/(238*(1-PG1)) 
for(i in 1:a){ 
for(j in 1:b){ 
y[i,j]~dbin(p[i,j],n[i])  
}} 
p[1,1]<-(SN*PG1)/((SN*PG1)+((1-SP)*(1-
PG1))) 
p[2,2]<-(SP*(1-PG1))/((SP*(1-PG1))+((1-
SN)*PG1))  
p[2,1]<-((1-SN)*PG1)/(((1-SN)*PG1)+(SP*(1-
PG1))) 
p[1,2]<-((1-SP)*(1-PG1))/(((1-SP)*(1-
PG1))+(SN*PG1)) 
sensitivity<-y[1,1]/(y[1,1]+y[2,1]) 
specificity<-y[2,2]/(y[2,1]+y[2,2]) 
} 
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